Counterfeit Pharmaceuticals

Counterfeit Pharmaceuticals is a pharmaceutical product that belongs to the category of medical counterfeits, distinguished by its deliberate and unauthorized misrepresentation of identity, source, or composition, including active ingredients, dosage, or manufacturer, thereby posing significant risks to public health and regulatory integrity.

160

Publications

7.4K

Citations

498

Authors

205

Institutions

Publications per year

2017–2026

41

Variants

Counterfeit DrugsFalsified Medical Products

Authors

498

  1. PN
    Paul N. Newton

    Mahosot Hospital, Laos

    7 publications · 1.2K citations

    7

    h-index

  2. FM
    Facundo M. Fernández

    Georgia Institute of Technology, United States

    6 publications · 879 citations

    6

    h-index

  3. NJ
    Nicholas J. White

    Mahidol University, Thailand

    4 publications · 746 citations

    4

    h-index

  4. MD
    Michael D. Green

    University of Michigan, United States

    4 publications · 360 citations

    4

    h-index

  5. RB
    Roger Bate

    American Enterprise Institute, United States

    4 publications · 171 citations

    4

    h-index

1–5 of 498

Venues

  1. PubMed

    Repository · 8 publications · 356 citations

    8

    h-index

  2. 7

    h-index

  3. PLoS Medicine

    4 publications · 638 citations

    4

    h-index

  4. The Lancet

    4 publications · 145 citations

    4

    h-index

  5. Talanta

    3 publications · 116 citations

    3

    h-index

1–5